Company page

Contineum Therapeutics, Inc.

Contineum Therapeutics, Inc. (ticker: CTNM) is a public company operating in the American market, with a market capitalization of approximately $446.4 million. The company focuses on developing innovative therapeutic solutions. Its commitment to advancing healthcare is reflected in its strategic initiatives and research efforts.